 | • レポートコード：QYR9ST04500 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、腎臓癌治療薬の世界市場について調査・分析し、腎臓癌治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫療法（IL-2））、用途別（病院、研究機関、診断センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腎臓癌治療薬市場動向 ・主要企業別マーケットシェア ・腎臓癌治療薬の種類別市場規模2014-2019 （血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫療法（IL-2）） ・腎臓癌治療薬の用途別市場規模2014-2019 （病院、研究機関、診断センター、その他） ・腎臓癌治療薬の北米市場：主要企業・種類別/用途別市場規模 ・腎臓癌治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・腎臓癌治療薬の中国市場：主要企業・種類別/用途別市場規模 ・腎臓癌治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・腎臓癌治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・腎臓癌治療薬のインド市場：主要企業・種類別/用途別市場規模 ・腎臓癌治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Amgen/Allergan、Argos Therapeutics、AstraZeneca、Aveo Pharmaceuticals、Bayer、Exelixis、Incyte、Merck、Roche、Pfizer、Bristol-Myers Squibb、Eisai、Prometheus Labs、Novartis） ・腎臓癌治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits.
In 2018, the global Kidney Cancer Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Kidney Cancer Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney Cancer Treatment Drugs development in United States, Europe and China.
The key players covered in this study
Amgen/Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Pfizer
Bristol-Myers Squibb
Eisai
Prometheus Labs
Novartis
Market segment by Type, the product can be split into
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Market segment by Application, split into
Hospitals
Research Institutes
Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Kidney Cancer Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Kidney Cancer Treatment Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Kidney Cancer Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Angiogenesis Inhibitors
1.4.3 mTOR Inhibitors
1.4.4 Monoclonal Antibodies
1.4.5 Cytokine Immunotherapy (IL-2)
1.5 Market by Application
1.5.1 Global Kidney Cancer Treatment Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Research Institutes
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Kidney Cancer Treatment Drugs Market Size
2.2 Kidney Cancer Treatment Drugs Growth Trends by Regions
2.2.1 Kidney Cancer Treatment Drugs Market Size by Regions (2014-2025)
2.2.2 Kidney Cancer Treatment Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Kidney Cancer Treatment Drugs Market Size by Manufacturers
3.1.1 Global Kidney Cancer Treatment Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Kidney Cancer Treatment Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Kidney Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Kidney Cancer Treatment Drugs Key Players Head office and Area Served
3.3 Key Players Kidney Cancer Treatment Drugs Product/Solution/Service
3.4 Date of Enter into Kidney Cancer Treatment Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Kidney Cancer Treatment Drugs Market Size by Type (2014-2019)
4.2 Global Kidney Cancer Treatment Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Kidney Cancer Treatment Drugs Market Size (2014-2019)
5.2 Kidney Cancer Treatment Drugs Key Players in United States
5.3 United States Kidney Cancer Treatment Drugs Market Size by Type
5.4 United States Kidney Cancer Treatment Drugs Market Size by Application
6 Europe
6.1 Europe Kidney Cancer Treatment Drugs Market Size (2014-2019)
6.2 Kidney Cancer Treatment Drugs Key Players in Europe
6.3 Europe Kidney Cancer Treatment Drugs Market Size by Type
6.4 Europe Kidney Cancer Treatment Drugs Market Size by Application
7 China
7.1 China Kidney Cancer Treatment Drugs Market Size (2014-2019)
7.2 Kidney Cancer Treatment Drugs Key Players in China
7.3 China Kidney Cancer Treatment Drugs Market Size by Type
7.4 China Kidney Cancer Treatment Drugs Market Size by Application
8 Japan
8.1 Japan Kidney Cancer Treatment Drugs Market Size (2014-2019)
8.2 Kidney Cancer Treatment Drugs Key Players in Japan
8.3 Japan Kidney Cancer Treatment Drugs Market Size by Type
8.4 Japan Kidney Cancer Treatment Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Kidney Cancer Treatment Drugs Market Size (2014-2019)
9.2 Kidney Cancer Treatment Drugs Key Players in Southeast Asia
9.3 Southeast Asia Kidney Cancer Treatment Drugs Market Size by Type
9.4 Southeast Asia Kidney Cancer Treatment Drugs Market Size by Application
10 India
10.1 India Kidney Cancer Treatment Drugs Market Size (2014-2019)
10.2 Kidney Cancer Treatment Drugs Key Players in India
10.3 India Kidney Cancer Treatment Drugs Market Size by Type
10.4 India Kidney Cancer Treatment Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Kidney Cancer Treatment Drugs Market Size (2014-2019)
11.2 Kidney Cancer Treatment Drugs Key Players in Central & South America
11.3 Central & South America Kidney Cancer Treatment Drugs Market Size by Type
11.4 Central & South America Kidney Cancer Treatment Drugs Market Size by Application
12 International Players Profiles
12.1 Amgen/Allergan
12.1.1 Amgen/Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Kidney Cancer Treatment Drugs Introduction
12.1.4 Amgen/Allergan Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.1.5 Amgen/Allergan Recent Development
12.2 Argos Therapeutics
12.2.1 Argos Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Kidney Cancer Treatment Drugs Introduction
12.2.4 Argos Therapeutics Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.2.5 Argos Therapeutics Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Kidney Cancer Treatment Drugs Introduction
12.3.4 AstraZeneca Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Aveo Pharmaceuticals
12.4.1 Aveo Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Kidney Cancer Treatment Drugs Introduction
12.4.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.4.5 Aveo Pharmaceuticals Recent Development
12.5 Bayer
12.5.1 Bayer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Kidney Cancer Treatment Drugs Introduction
12.5.4 Bayer Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.5.5 Bayer Recent Development
12.6 Exelixis
12.6.1 Exelixis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Kidney Cancer Treatment Drugs Introduction
12.6.4 Exelixis Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.6.5 Exelixis Recent Development
12.7 Incyte
12.7.1 Incyte Company Details
12.7.2 Company Description and Business Overview
12.7.3 Kidney Cancer Treatment Drugs Introduction
12.7.4 Incyte Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.7.5 Incyte Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Kidney Cancer Treatment Drugs Introduction
12.8.4 Merck Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.8.5 Merck Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Kidney Cancer Treatment Drugs Introduction
12.9.4 Roche Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.9.5 Roche Recent Development
12.10 Pfizer
12.10.1 Pfizer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Kidney Cancer Treatment Drugs Introduction
12.10.4 Pfizer Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)
12.10.5 Pfizer Recent Development
12.11 Bristol-Myers Squibb
12.12 Eisai
12.13 Prometheus Labs
12.14 Novartis
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Kidney Cancer Treatment Drugs Key Market Segments
Table Key Players Kidney Cancer Treatment Drugs Covered
Table Global Kidney Cancer Treatment Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Kidney Cancer Treatment Drugs Market Size Market Share by Type 2014-2025
Figure Angiogenesis Inhibitors Figures
Table Key Players of Angiogenesis Inhibitors
Figure mTOR Inhibitors Figures
Table Key Players of mTOR Inhibitors
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Cytokine Immunotherapy (IL-2) Figures
Table Key Players of Cytokine Immunotherapy (IL-2)
Table Global Kidney Cancer Treatment Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Research Institutes Case Studies
Figure Diagnostic Centers Case Studies
Figure Others Case Studies
Figure Kidney Cancer Treatment Drugs Report Years Considered
Table Global Kidney Cancer Treatment Drugs Market Size 2014-2025 (Million US$)
Figure Global Kidney Cancer Treatment Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Kidney Cancer Treatment Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Kidney Cancer Treatment Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Kidney Cancer Treatment Drugs Market Share by Regions 2014-2019
Figure Global Kidney Cancer Treatment Drugs Market Share by Regions 2014-2019
Figure Global Kidney Cancer Treatment Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Kidney Cancer Treatment Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Kidney Cancer Treatment Drugs Market Share by Manufacturers (2014-2019)
Figure Global Kidney Cancer Treatment Drugs Market Share by Manufacturers in 2018
Table Global Kidney Cancer Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Kidney Cancer Treatment Drugs Product/Solution/Service
Table Date of Enter into Kidney Cancer Treatment Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Kidney Cancer Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Kidney Cancer Treatment Drugs Market Size Share by Type (2014-2019)
Figure Global Kidney Cancer Treatment Drugs Market Size Market Share by Type (2014-2019)
Table Global Kidney Cancer Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Kidney Cancer Treatment Drugs Market Size Share by Application (2014-2019)
Figure Global Kidney Cancer Treatment Drugs Market Size Market Share by Application (2014-2019)
Figure Global Kidney Cancer Treatment Drugs Revenue Market Share by Application in 2018
Figure United States Kidney Cancer Treatment Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Kidney Cancer Treatment Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Kidney Cancer Treatment Drugs Market Share (2018-2019)
Table United States Kidney Cancer Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Kidney Cancer Treatment Drugs Market Share by Type (2014-2019)
Table United States Kidney Cancer Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Kidney Cancer Treatment Drugs Market Share by Application (2014-2019)
Figure Europe Kidney Cancer Treatment Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Kidney Cancer Treatment Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Kidney Cancer Treatment Drugs Market Share (2018-2019)
Table Europe Kidney Cancer Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Kidney Cancer Treatment Drugs Market Share by Type (2014-2019)
Table Europe Kidney Cancer Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Kidney Cancer Treatment Drugs Market Share by Application (2014-2019)
Figure China Kidney Cancer Treatment Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Kidney Cancer Treatment Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Kidney Cancer Treatment Drugs Market Share (2018-2019)
Table China Kidney Cancer Treatment Drugs Market Size by Type (2014-20189) (Million US$)
Table China Kidney Cancer Treatment Drugs Market Share by Type (2014-2019)
Table China Kidney Cancer Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table China Kidney Cancer Treatment Drugs Market Share by Application (2014-2019)
Figure Japan Kidney Cancer Treatment Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Kidney Cancer Treatment Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Kidney Cancer Treatment Drugs Market Share (2018-2019)
Table Japan Kidney Cancer Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Kidney Cancer Treatment Drugs Market Share by Type (2014-2019)
Table Japan Kidney Cancer Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Kidney Cancer Treatment Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Kidney Cancer Treatment Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Kidney Cancer Treatment Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Kidney Cancer Treatment Drugs Market Share (2018-2019)
Table Southeast Asia Kidney Cancer Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Kidney Cancer Treatment Drugs Market Share by Type (2014-2019)
Table Southeast Asia Kidney Cancer Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Kidney Cancer Treatment Drugs Market Share by Application (2014-2019)
Figure India Kidney Cancer Treatment Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Kidney Cancer Treatment Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Kidney Cancer Treatment Drugs Market Share (2018-2019)
Table India Kidney Cancer Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table India Kidney Cancer Treatment Drugs Market Share by Type (2014-2019)
Table India Kidney Cancer Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table India Kidney Cancer Treatment Drugs Market Share by Application (2014-2019)
Figure Central & South America Kidney Cancer Treatment Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Kidney Cancer Treatment Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Kidney Cancer Treatment Drugs Market Share (2018-2019)
Table Central & South America Kidney Cancer Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Kidney Cancer Treatment Drugs Market Share by Type (2014-2019)
Table Central & South America Kidney Cancer Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Kidney Cancer Treatment Drugs Market Share by Application (2014-2019)
Table Amgen/Allergan Company Details
Table Amgen/Allergan Revenue in Kidney Cancer Treatment Drugs Business (2014-2019) (Million US$)
Figure Amgen/Allergan Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table Amgen/Allergan Recent Development
Table Argos Therapeutics Company Details
Table Argos Therapeutics Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)(Million US$)
Figure Argos Therapeutics Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table Argos Therapeutics Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Aveo Pharmaceuticals Company Details
Table Aveo Pharmaceuticals Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)(Million US$)
Figure Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table Aveo Pharmaceuticals Recent Development
Table Bayer Company Details
Table Bayer Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table Bayer Recent Development
Table Exelixis Company Details
Table Exelixis Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)(Million US$)
Figure Exelixis Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table Exelixis Recent Development
Table Incyte Company Details
Table Incyte Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)(Million US$)
Figure Incyte Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table Incyte Recent Development
Table Merck Company Details
Table Merck Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table Merck Recent Development
Table Roche Company Details
Table Roche Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Kidney Cancer Treatment Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Kidney Cancer Treatment Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Bristol-Myers Squibb Company Details
Table Eisai Company Details
Table Prometheus Labs Company Details
Table Novartis Company Details
Table Global Kidney Cancer Treatment Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Kidney Cancer Treatment Drugs Market Size Share by Regions (2019-2025)
Figure Global Kidney Cancer Treatment Drugs Market Size Share by Regions in 2025
Figure United States Kidney Cancer Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Kidney Cancer Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Kidney Cancer Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Kidney Cancer Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Kidney Cancer Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Kidney Cancer Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Kidney Cancer Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Kidney Cancer Treatment Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Kidney Cancer Treatment Drugs Market Size by Product (2019-2025)
Figure Global Kidney Cancer Treatment Drugs Market Size by Product in 2025
Table Global Kidney Cancer Treatment Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Kidney Cancer Treatment Drugs Market Size by Application (2019-2025)
Figure Global Kidney Cancer Treatment Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …
- 前立腺癌治療薬の世界市場：市場規模・現状・予測 Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players ar…
- 腎線維症治療の世界市場：市場規模・現状・予測 Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.Increasing prevalence of chronic diseases such as kidney disorders is expected to trigger the growth of this market over the forecast period. Changing life…
- mTOR阻害剤の世界市場：インサイト・予測 mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR).Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell …